Mollie H. Wright

1.1k total citations
10 papers, 801 citations indexed

About

Mollie H. Wright is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Mollie H. Wright has authored 10 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Toxicology. Recurrent topics in Mollie H. Wright's work include Cancer therapeutics and mechanisms (3 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Heat shock proteins research (3 papers). Mollie H. Wright is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Heat shock proteins research (3 papers). Mollie H. Wright collaborates with scholars based in United States, Russia and Poland. Mollie H. Wright's co-authors include Lyuba Varticovski, Anna Maria Calcagno, Suresh V. Ambudkar, Crystal D. Salcido, Ana I. Robles, Keli Agama, Andrew Morrell, Smitha Antony, Mark Cushman and Muthukaman Nagarajan and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Mollie H. Wright

10 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mollie H. Wright United States 8 517 505 184 61 57 10 801
Anthony J. Kozielski United States 14 440 0.9× 608 1.2× 81 0.4× 59 1.0× 106 1.9× 22 800
Yi He Ling United States 12 381 0.7× 580 1.1× 113 0.6× 46 0.8× 25 0.4× 15 855
Giacomo Cossa Italy 17 352 0.7× 650 1.3× 148 0.8× 83 1.4× 32 0.6× 26 926
Diane E. Brattain United States 16 492 1.0× 731 1.4× 229 1.2× 30 0.5× 39 0.7× 19 1.1k
Linxiang Lan United Kingdom 14 272 0.5× 685 1.4× 330 1.8× 44 0.7× 31 0.5× 17 965
Marina Stantic Australia 12 266 0.5× 449 0.9× 225 1.2× 52 0.9× 12 0.2× 14 699
Katherine Kravik Norway 9 306 0.6× 358 0.7× 128 0.7× 21 0.3× 15 0.3× 11 652
Sylaja Murikipudi United States 6 238 0.5× 225 0.4× 95 0.5× 21 0.3× 46 0.8× 8 470
James E. Gervasoni United States 10 352 0.7× 393 0.8× 70 0.4× 28 0.5× 19 0.3× 15 725
Dongkyoo Park United States 14 287 0.6× 545 1.1× 137 0.7× 26 0.4× 16 0.3× 19 802

Countries citing papers authored by Mollie H. Wright

Since Specialization
Citations

This map shows the geographic impact of Mollie H. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mollie H. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mollie H. Wright more than expected).

Fields of papers citing papers by Mollie H. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mollie H. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mollie H. Wright. The network helps show where Mollie H. Wright may publish in the future.

Co-authorship network of co-authors of Mollie H. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Mollie H. Wright. A scholar is included among the top collaborators of Mollie H. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mollie H. Wright. Mollie H. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wright, Mollie H., et al.. (2008). Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics. Breast Cancer Research. 10(1). R10–R10. 487 indexed citations
2.
Svirshchevskaya, E. V., Jacopo Mariotti, Mollie H. Wright, et al.. (2008). Rapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunity. BMC Cancer. 8(1). 176–176. 20 indexed citations
3.
Wright, Mollie H., Ana I. Robles, Jason I. Herschkowitz, et al.. (2008). Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1. Molecular Cancer. 7(1). 29–29. 31 indexed citations
4.
Koll, Thuy T., Mollie H. Wright, Mekel M. Richardson, et al.. (2008). HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair. Molecular Cancer Therapeutics. 7(7). 1985–1992. 68 indexed citations
5.
Antony, Smitha, Keli Agama, Ze‐Hong Miao, et al.. (2007). Novel Indenoisoquinolines NSC 725776 and NSC 724998 Produce Persistent Topoisomerase I Cleavage Complexes and Overcome Multidrug Resistance. Cancer Research. 67(21). 10397–10405. 113 indexed citations
6.
Pommier, Yves, Smitha Antony, Ze‐Hong Miao, et al.. (2007). Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance. Molecular Cancer Therapeutics. 6. 1 indexed citations
7.
Varticovski, Lyuba, Mollie H. Wright, Eloisi Caldas-Lopes, Gabriela Chiosis, & Ana I. Robles. (2007). Synergy of the Purine-Scaffold HSP90 Inhibitor, PU-H71, with Doxorubicin in Non-Hodgkin’s Lymphoma Cell Lines.. Blood. 110(11). 1399–1399. 2 indexed citations
8.
9.
10.
Wingfield, Wayne E., David C. Twedt, Robert W. Moore, Michael S. Leib, & Mollie H. Wright. (1982). Acid-base and electrolyte values in dogs with acute gastric dilatation-volvulus. Journal of the American Veterinary Medical Association. 180(9). 1070–1072. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony J. Kozielski Breakdown of academic impact, for papers by Yi He Ling Breakdown of academic impact, for papers by Giacomo Cossa Breakdown of academic impact, for papers by Diane E. Brattain Breakdown of academic impact, for papers by Linxiang Lan Breakdown of academic impact, for papers by Marina Stantic Breakdown of academic impact, for papers by Katherine Kravik Breakdown of academic impact, for papers by Sylaja Murikipudi Breakdown of academic impact, for papers by James E. Gervasoni Breakdown of academic impact, for papers by Dongkyoo Park
Rankless by CCL
2026